Cite Filings / NTLA
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)

CIK 0001652130

  • Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364785571
Phone
+1 857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
Filings Financials Insiders Search text
All 727 Financials 185 Shareholder Meetings 12 Executive Compensation 161 Insider Trading 353 Beneficial Ownership Interest 86 Business Combinations 140 Public Offerings 42 Mutual Funds and ETFs 10 Others 59
›
Filed in
  1. No filings match these filters. Clear filters
  2. 8-K Event ● Results of operations 2016-11-01
  3. 10-Q Report Quarterly Report 2016-08-04
  4. 8-K Event ● Results of operations 2016-08-04
  5. 10-Q Report Quarterly Report 2016-06-03
  6. 8-K Event Unregistered share sale · Bylaws or fiscal year change · Other events 2016-05-17

Page 10 of 10 · 185 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…